Filtered By:
Condition: Ischemic Stroke
Countries: China Health
This page shows you your search results in order of date. This is page number 17.
Order by Relevance | Date
Total 2797 results found since Jan 2013.
Association between HMGB1 genetic variants and ischemic stroke susceptibility, onset age, and recurrence risk among Chinese Han individuals
CONCLUSIONS: Our study provided evidence for the association between HMGB1 polymorphisms and ischemic stroke susceptibility and recurrence, indicating that HMGB1 gene variants may be potential markers for first and secondary stroke prevention.PMID:37303653 | PMC:PMC10251027
Source: American Journal of Translational Research - June 12, 2023 Category: Research Authors: Luying Qiu Long Li Zhiyi He Fang Liu Shumin Deng Yanzhe Wang Source Type: research
Recombinant tissue-type plasminogen activator (rt-PA) effectively restores neurological function and improves prognosis in acute ischemic stroke
CONCLUSION: Compared with conventional pharmacological regimens, additional rt-PA intravenous thrombolytic therapy improves the clinical outcome of patients with acute ischemic stroke, promotes neurological recovery, and enhances patient prognosis without increasing the risk of patient-related adverse events.PMID:37303683 | PMC:PMC10251022
Source: American Journal of Translational Research - June 12, 2023 Category: Research Authors: Shouyun Zhang Dezhen Wang Lin Li Source Type: research
Association between HMGB1 genetic variants and ischemic stroke susceptibility, onset age, and recurrence risk among Chinese Han individuals
CONCLUSIONS: Our study provided evidence for the association between HMGB1 polymorphisms and ischemic stroke susceptibility and recurrence, indicating that HMGB1 gene variants may be potential markers for first and secondary stroke prevention.PMID:37303653 | PMC:PMC10251027
Source: American Journal of Translational Research - June 12, 2023 Category: Research Authors: Luying Qiu Long Li Zhiyi He Fang Liu Shumin Deng Yanzhe Wang Source Type: research
Recombinant tissue-type plasminogen activator (rt-PA) effectively restores neurological function and improves prognosis in acute ischemic stroke
CONCLUSION: Compared with conventional pharmacological regimens, additional rt-PA intravenous thrombolytic therapy improves the clinical outcome of patients with acute ischemic stroke, promotes neurological recovery, and enhances patient prognosis without increasing the risk of patient-related adverse events.PMID:37303683 | PMC:PMC10251022
Source: American Journal of Translational Research - June 12, 2023 Category: Research Authors: Shouyun Zhang Dezhen Wang Lin Li Source Type: research
Chronic disease self-efficacy and factors influencing this in patients with ischemic stroke
CONCLUSION: Chronic disease self-efficacy in patients with ischemic stroke was at an intermediate to high level. History of falls in the previous year, physical dysfunction, and cognitive impairment were factors influencing patients' chronic disease self-efficacy.PMID:37302056 | DOI:10.3233/THC-230145
Source: Technology and Health Care - June 11, 2023 Category: Medical Devices Authors: Mei Wang Yali Liu Source Type: research
